Search Results - "Beyer, Carl F"
-
1
Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia
Published in Bioconjugate chemistry (01-01-2002)“…CD33 is expressed by acute myeloid leukemia (AML) cells in >80% of patients but not by normal hematopoietic stem cells, suggesting that elimination of CD33+…”
Get full text
Journal Article -
2
Parallel synthesis and biological evaluation of 5,6,7,8-tetrahydrobenzothieno[2,3- d]pyrimidin-4(3H)-one cytotoxic agents selective for p21-deficient cells
Published in Bioorganic & medicinal chemistry letters (01-11-2005)“…A novel series of anti-proliferative agents containing the thieno[2,3- d]pyrimidin-4-one scaffold and the structure–activity relationship studies to improve…”
Get full text
Journal Article -
3
microtubule-active antitumor compound TTI-237 has both paclitaxel-like and vincristine-like properties
Published in Cancer chemotherapy and pharmacology (01-09-2009)“…Purpose To compare TTI-237 (5-chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-[1, 2,…”
Get full text
Journal Article -
4
TTI-237 : A Novel Microtubule-Active Compound with In vivo Antitumor Activity
Published in Cancer research (Chicago, Ill.) (01-04-2008)“…5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine butanedioate…”
Get full text
Journal Article -
5
An Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia. Choice of Linker
Published in Bioconjugate chemistry (01-01-2002)“…The anti-CD33 antibody, P67.6, has been chosen to target the potently cytotoxic calicheamicin antitumor antibiotics to acute myeloid leukemia (AML) due to the…”
Get full text
Journal Article -
6
An Anti-MUC1 Antibody−Calicheamicin Conjugate for Treatment of Solid Tumors. Choice of Linker and Overcoming Drug Resistance
Published in Bioconjugate chemistry (01-03-2005)“…The anti-MUC1 antibody, CTM01, has been chosen to target the potently cytotoxic calicheamicin antitumor antibiotics to solid tumors of epithelial origin that…”
Get full text
Journal Article -
7
A Calicheamicin Conjugate with a Fully Humanized Anti-MUC1 Antibody Shows Potent Antitumor Effects in Breast and Ovarian Tumor Xenografts
Published in Bioconjugate chemistry (01-03-2005)“…Murine CTM01 is an internalizing murine IgG1 monoclonal antibody that recognizes the MUC1 antigen expressed on many solid tumors of epithelial origin…”
Get full text
Journal Article -
8
Synthesis and activity of novel analogs of hemiasterlin as inhibitors of tubulin polymerization: modification of the A segment
Published in Bioorganic & medicinal chemistry letters (01-11-2004)“…Analogs of hemiasterlin (1) and HTI-286 (2), which contain various aromatic rings in the A segment, were synthesized as potential inhibitors of tubulin…”
Get full text
Journal Article -
9
A 'dot-immunobinding assay' on nitrocellulose membrane for the determination of the immunoglobulin class of mouse monoclonal antibodies
Published in Journal of immunological methods (24-02-1984)“…A rapid and convenient procedure for the determination of the immunoglobulin class of mouse monoclonal antibodies is described. Hybridoma supernatants or other…”
Get more information
Journal Article -
10
Studies of individual amino acid residues of the decapeptide tyrocidine A by proton double-resonance difference spectroscopy in the correlation mode
Published in Biochemistry (Easton) (01-01-1975)“…The cyclic decapeptide antibiotic tyrocidine A was studied by two relatively new methods, viz., correlation proton magnetic resonance (pmr) spectroscopy and…”
Get full text
Journal Article -
11
-
12
Heterogeneous Tryptophan Environments in the Cyclic Peptides Tyrocidines B and C
Published in The Journal of biological chemistry (25-05-1974)“…Phosphorescence spectroscopy has been used to probe the microenvironments of the tryptophan residues of the cyclic antibiotic decapeptides tyrocidine B (which…”
Get full text
Journal Article -
13
Lymphocyte Transformation Induced by Chemical Modification of Membrane Components
Published in The Journal of immunology (1950) (01-11-1978)“…Abstract Neuraminidase treatment of responder cells in indirect periodate or indirect neuraminidase-galactose oxidase (NGO) stimulation of rat lymph node cells…”
Get full text
Journal Article -
14
Rat Dendritic Cells Function as Accessory Cells and Control the Production of a Soluble Factor Required for Mitogenic Responses of T Lymphocytes
Published in Proceedings of the National Academy of Sciences - PNAS (01-09-1980)“…Transformation of T lymphocytes, induced by treatment with periodate or with neuraminidase plus galactose oxidase, requires the participation of accessory…”
Get full text
Journal Article -
15
Lymphocyte Transformation Induced by Chemical Modification of Membrane Components
Published in The Journal of immunology (1950) (01-12-1977)“…Abstract Reliable culture conditions and a valid 3H-thymidine labeling procedure were established for studies on the in vitro response of rat lymph node cells…”
Get full text
Journal Article -
16
-
17
-
18
Periodate and Concanavalin A Induce Blast Transformation of Rat Lymphocytes by an Indirect Mechanism
Published in Proceedings of the National Academy of Sciences - PNAS (01-09-1975)“…When rat lymph node cells, rendered incapable of division by treatment with mitomycin C, were then reacted with sodium metaperiodate (NaIO4), they stimulated…”
Get full text
Journal Article -
19
Cell-cell interactions in blast transformation of rat lymphocytes by neuraminidase and galactose oxidase
Published in Experimental cell research (01-10-1977)Get more information
Journal Article